Please assess the completion status of the following clinical trial:

Trial Title: Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients,~* Aged \> than equal to 18 years,~* Patient presenting with an OHT or OAG with an IOP � 21 mmHg,~* Patient currently treated with ophthalmic beta-blockers monotherapy and requiring a change of the ophthalmic medication due to insufficient response to treatment,~Exclusion Criteria:~* Patient currently treated by or having received within the last month any ophthalmic hypotensive agent other than a beta-blocker,~* Patient presenting any contraindication to latanoprost or timolol,~* Patient with history of asthma, obstructive broncho-pneumopathy, sinusal bradycardia (pulse rate \< 60 bpm), auriculo-ventricular block, cardiac insufficiency, Raynaud disease or any other condition that would preclude the patient from taking the prescribed medication,~* Patient with known intolerance to benzalkonium chloride or any excipient contained in the trial treatment,

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active (Type: EXPERIMENTAL): None
- Procedure (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).